Screening for beneficial effects of oral intake of sweet corn by DNA microarray analysis

Yoshihiko Tokuji1, Kyoko Akiyama, Keita Yunoki

  • 1Dept of Agriculture and Life Science, Obihiro Univ of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan. tokuji@obihiro.ac.jp

Journal of Food Science
|November 10, 2009
PubMed

Insights

Sweet corn intake modulates cell proliferation and programmed cell death, potentially suppressing cancer. Studies show dietary sweet corn inhibits tumor growth in mice, suggesting its value in cancer prevention.

Area of Science:

  • Nutritional Science
  • Molecular Biology
  • Oncology

Background:

  • The potential health benefits of dietary sweet corn are not fully understood.
  • Investigating the molecular mechanisms underlying sweet corn's effects on cellular processes is crucial.

Purpose of the Study:

  • To identify novel functions of oral sweet corn intake.
  • To elucidate the molecular pathways modulated by dietary sweet corn.

Main Methods:

  • DNA microarray analysis was performed on the livers of mice fed with sweet corn.
  • Functional annotation clustering identified genes affected by sweet corn intake ( > 1.5-fold change).
  • Gene expression analysis focused on cell cycle regulators and apoptosis-related genes.

Main Results:

  • Dietary sweet corn modulated both cell proliferation and programmed cell death.
  • Sweet corn intake downregulated Jun and beta-catenin in the Wnt signaling pathway.
  • Upregulation of cell cycle negative regulators (Rb, p53) and pro-apoptotic genes (BOK, BID, CASP4) was observed.
  • Oral sweet corn administration significantly inhibited tumor growth by 36.6% (P < 0.05) in mice with Ehrlich tumor cells.

Conclusions:

  • Sweet corn intake influences key molecular pathways involved in cell cycle regulation and apoptosis.
  • These findings suggest sweet corn possesses anti-cancer properties.
  • Dietary sweet corn demonstrates potential as a functional food for cancer suppression.